NCT01764178.
Methods | Randomised, open‐label, cross‐over trial |
Participants | Healthy male volunteers Age 20‐55 years at the time of screening BMI 19‐26 kg/m2 at the time of screening |
Interventions | Livalo fixed combination drug (pitavastatin + valsartan) Comparator: pitavastatin, valsartan |
Outcomes |
Primary outcomes:
Secondary outcomes:
|
Notes |